Results also showed age-adjusted rate of drug overdose deaths decreased from 2022 to 2023, after increasing over 20 years

Findings seen for both all-cause and cause-specific hospital admissions

Findings show persistent posttreatment genital hypoesthesia among sexual and gender minority youth with history of antidepressant use

Significantly increased risks seen for major adverse cardiovascular events and any cardiovascular condition

taVNS significantly reduces insomnia severity and is associated with sustained benefits over 20 weeks

In the context of coaching calls, neither nicotine replacement therapy nor mHealth interventions significantly add to the quit rate

Findings seen among younger Black women followed for seven years

SSRI-exposed children did not have increased risk of functional nausea and vomiting or functional abdominal pain disorders